| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |